Ginkgo Bioworks Holdings Inc (NYSE:DNA.WS)
$ 0.0371 0.0001 (0.27%) Market Cap: - Enterprise Value: - PE Ratio: 0 PB Ratio: 1.45 GF Score: 19/100

Ginkgo Bioworks Holdings Inc at Morgan Stanley Global Healthcare Conference Transcript

Sep 13, 2023 / 04:55PM GMT
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

All right. Good morning, everyone. I'm Tejas Savant. I cover the Life Sciences space here at Morgan Stanley. Before we get started, for important disclosures, please see the Morgan Stanley research disclosure website at morganstanley.com/researchdisclosures. And if you have any questions, do reach out to your sales rep.

So it's my pleasure to host Ginkgo Bioworks today. And from the company, we have Anna Marie Wagner, Senior Vice President of Corporate Development. So thank you for joining us, Anna Marie.

Anna Marie Wagner
Ginkgo Bioworks Holdings, Inc. - SVP of Corporate Development

Happy to be here.

Questions & Answers

Tejas Rajeev Savant;Anna Marie Wagner
Morgan Stanley, Research Division - Equity Analyst;

Maybe just to kick things off, can you share some of Ginkgo's sort of key accomplishments over the course of the past year? And what are you most excited about as we head into 2024?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot